GYRE THERAPEUTICS Trademark
Trademark Overview
On Monday, June 23, 2025, a trademark application was filed for GYRE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GYRE THERAPEUTICS trademark a serial number of 99248258. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, June 2, 2026. This trademark is owned by Gyre Therapeutics, Inc.. The GYRE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers
General Information
| Serial Number | 99248258 |
| Word Mark | GYRE THERAPEUTICS |
| Filing Date | Monday, June 23, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, June 2, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 23, 2026 |
Trademark Statements
| NOT AVAILABLE | "THERAPEUTICS" |
| Description of Mark | The mark consists of five crescent shapes arranged to form a circle, a capsule shape resembling a pill inside the circle, the capsule having a half crescent shape cutting into the capsule, letters forming the phrase “GYRE” with the letter “G” in capital letter situated to the right of the circle, and letters forming the phrase “THERAPEUTICS” situated underneath the phrase “GYRE”. |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers |
| Goods and Services | Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 23, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 23, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, October 30, 2023 |
| First Use In Commerce Date | Monday, October 30, 2023 |
Trademark Owner History
| Party Name | Gyre Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92130
US |
Trademark Events
| Event Date | Event Description |
| Monday, June 23, 2025 | NEW APPLICATION ENTERED |
| Monday, June 23, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, October 30, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, October 30, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, November 12, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, November 19, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 19, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 13, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, February 13, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Monday, May 4, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, May 4, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 4, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 22, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, May 22, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Friday, May 22, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Friday, May 22, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, May 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
